Abstract:PURPOSE:To review intermediate-term clinical outcomes of microwave ablation (MWA) compared with open radial nephrectomy (ORN) in small renal cell carcinoma (RCC) patients and to identify prognostic factors associated with two techniques.MATERIALS AND METHODS:This retrospective study was institutional review board-approved. A total of 163 patients (127 men and 36 women) with small RCC (≤4 cm) were included from April 2006 to March 2012. Sixty-five patients underwent MWA and 98 patients underwent ORN. Survival, recurrence, and renal function changes were compared between the two groups. Effect of changes in key parameters (ie, overall survival, RCC-related survival, and metastasis-free survival) was statistically analyzed with the log-rank test.RESULTS:Although overall survival after MWA was lower than that after ORN (P = .002), RCC-related survival was comparable to ORN (P = .78). Estimated 5-year overall survival rates were 67.3% after MWA and 97.8% after ORN; for RCC-related survival, estimated 5-year rates were 97.1% after MWA and 97.8% after ORN. There was one local tumor recurrence 32 months after MWA and none after ORN. Major complication rates were comparable (P = .81) between the two techniques (MWA, 2.5% vs ORN, 3.1%). The MWA group had less surgical time (P < .001), estimated blood loss (P < .001), and postoperative hospitalization (P < .001). Multivariate analysis showed age (P = .014), tumor type (P = .003), postoperative urea nitrogen (P = .042), comorbid disease (P = .005), and treatment modality (P < .001) may become survival rate predictors.CONCLUSION:In intermediate term, ultrasonographically guided percutaneous MWA and ORN provide comparable results in oncologic outcomes. MWA appears to be a safe and effective technique for management of small RCC in patients with little loss of renal function.

Minimally Invasive Treatment of Renal Cell Carcinoma

Ultrasound-guided Percutaneous Microwave Ablation of Renal Neoplasms

Development of Renal Tumor Ablation

Ultrasound guided percutaneous microwave ablation for small renal cancer: initial experience.

Update of percutaneous microwave ablation for renal cell carcinoma

Local thermal ablation of renal cell carcinoma.

Percutaneous radiofrequency ablation: minimally invasive therapy for renal tumors

Radiofrequency Ablation, Cryoablation, and Microwave Ablation for the Treatment of Small Renal Masses: Efficacy and Complications

Long-term Effects of Ultrasound-Guided Microwave Ablation in the Treatment of Small Renal Cell Carcinoma

Treatment of Renal Tumors with Ultrasound-Guided Percutaneous Radiofrequency Ablation

Percutaneous Microwave Ablation of Renal Cell Carcinoma: Practice Guidelines of the Ultrasound Committee of Chinese Medical Association, Interventional Oncology Committee of Chinese Research Hospital Association.

Status and progress of cryoablation of renal malignant tumors

Ultrasound guided percutaneous microwave ablation treatment for renal carcinomas at T1a stage: the safety evaluation in clinical application

Initial clinical study of ultrasound guided percutaneous microwave ablation treatment for kidney tumors at T1a stage

Efficacy of ultrasound-guided radio-frequency ablation for the treatment of 32 small renal tumors

Us-Guided Percutaneous Microwave Ablation of Renal Cell Carcinoma: Intermediate-Term Results

Efficacy of Contrast-Enhanced Ultrasound-Guided Percutaneous Microwave Ablation Treatment of Renal Carcinomas

Imaging-guided radiofrequency ablation for the treatment of tumors:its current status and progress

Laparoscopic Cool-Tip Radiofrequency Ablation for Renal Cell Carcinoma

Ultrasound-guided Percutaneous Microwave Ablation of Bilateral Renal Cell Carcinomas: Focus Upon Safety and Efficacy.

US-guided Percutaneous Microwave Ablation Versus Open Radical Nephrectomy for Small Renal Cell Carcinoma: Intermediate-Term Results.